Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator.
about
Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregatesThrombolytic effect of a plasminogen-plasminogen activator chimera in a photochemically induced thrombosis (PIT) modelThe interaction between components of the fibrinolytic system and GPIb/V/IX of platelets thrombus formation in mice.Role of thromboxane A2 in muscle injury following ischaemia.
P2860
Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Effects of vapiprost, a novel ...... ue-type plasminogen activator.
@en
Effects of vapiprost, a novel ...... ue-type plasminogen activator.
@nl
type
label
Effects of vapiprost, a novel ...... ue-type plasminogen activator.
@en
Effects of vapiprost, a novel ...... ue-type plasminogen activator.
@nl
prefLabel
Effects of vapiprost, a novel ...... ue-type plasminogen activator.
@en
Effects of vapiprost, a novel ...... ue-type plasminogen activator.
@nl
P2093
P2860
P1476
Effects of vapiprost, a novel ...... ue-type plasminogen activator.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1992.TB14370.X
P407
P577
1992-07-01T00:00:00Z